Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001773

CERILLIANT™ Norquetiapine-D8 Hydrochloride Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001773 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-773 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-773 Supplier MilliporeSigma Supelco Supplier No. N1211ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

This internal standard Certified Spiking Solution™ is applicable to numerous GC/MS and LC/MS applications including quantitation of patient levels, forensic and forensic toxicology analysis, isotope dilution methods, and calibrator preparation. Norquetiapine is a primary active metabolite of quetiapine, marketed as the atypical antipsychotic Seroquel for the treatment of depression, bipolar disorder, and schizophrenia. It maintains most of the pharmacological effects of quetiapine with potencies similar to the parent drug.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1
Linear Formula C17H9D8N3S · HCl
Concentration 100 μg/mL in methanol (as free base)
Formula Weight 339.91
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.